Yerui Pharmaceutical

Zhejiang Yerui Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the research, development, and production of high-quality active pharmaceutical ingredients (APIs) and advanced chemical intermediates. The company has established a significant presence in the oncology sector, manufacturing a wide range of tyrosine kinase inhibitors such as Imatinib, Gefitinib, and Osimertinib. Beyond oncology, Yerui produces APIs for antiviral treatments, including Entecavir and Tenofovir, and cardiovascular medications. Operating under strict GMP standards, the company serves as a critical supplier to the global pharmaceutical industry, providing both catalog products and custom synthesis services. Their facilities are designed to support large-scale chemical synthesis and rigorous quality control to meet international regulatory requirements.